Accenture to Help Santen Pharmaceutical Build a Global Intelligent Enterprise Platform on SAP® S/4HANA® to Drive Its Digital Transformation
TOKYO; Oct. 30, 2019 – Accenture (NYSE: ACN) has been selected to help Santen Pharmaceutical Co., Ltd. (Santen), an ophthalmic pharmaceutical company headquartered in Japan, build a global intelligent enterprise platform that will drive the company’s digital transformation.
from News | Accenture Newsroom https://ift.tt/2Nq3Z7Q
from News | Accenture Newsroom https://ift.tt/2Nq3Z7Q
Comments
Post a Comment